Isolation and Characterization of Cholera Toxin Gene-Positive Vibrio cholerae Non-O1/Non-O139 Isolated from Urinary Tract Infection: A Case Report DOI Creative Commons

Reem Aljindan,

Reema Allahham,

Rana A. Alghamdi

et al.

Infection and Drug Resistance, Journal Year: 2024, Volume and Issue: Volume 17, P. 1147 - 1152

Published: March 1, 2024

Urinary tract infection (UTI) caused by

Language: Английский

Two centuries of vaccination: historical and conceptual approach and future perspectives DOI Creative Commons
David A. Montero, Roberto Vidal,

Juliana Velasco

et al.

Frontiers in Public Health, Journal Year: 2024, Volume and Issue: 11

Published: Jan. 9, 2024

Over the past two centuries, vaccines have been critical for prevention of infectious diseases and are considered milestones in medical public health history. The World Health Organization estimates that vaccination currently prevents approximately 3.5-5 million deaths annually, attributed to such as diphtheria, tetanus, pertussis, influenza, measles. Vaccination has instrumental eradicating important pathogens, including smallpox virus wild poliovirus types 2 3. This narrative review offers a detailed journey through history advancements vaccinology, tailored healthcare workers. It traces pivotal milestones, beginning with variolation practices early 17th century, development first vaccine, continuous evolution innovation vaccine up present day. We also briefly immunological principles underlying vaccination, well main types, special mention recently introduced mRNA technology. Additionally, we discuss broad benefits vaccines, their role reducing morbidity mortality, fostering socioeconomic communities. Finally, address issue hesitancy effective strategies promote acceptance. Research, collaboration, widespread acceptance use imperative continued success programs controlling ultimately diseases.

Language: Английский

Citations

40

Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections DOI Creative Commons
Marco Palma, Ben-Quan Qi

Infectious Disease Reports, Journal Year: 2024, Volume and Issue: 16(6), P. 1127 - 1181

Published: Nov. 28, 2024

Background: Phage therapy, a treatment utilizing bacteriophages to combat bacterial infections, is gaining attention as promising alternative antibiotics, particularly for managing antibiotic-resistant bacteria. This study aims provide comprehensive review of phage therapy by examining its safety, efficacy, influencing factors, future prospects, and regulatory considerations. The also seeks identify strategies optimizing application propose systematic framework clinical implementation. Methods: A analysis preclinical studies, trials, frameworks was undertaken evaluate the therapeutic potential therapy. included an in-depth assessment key factors outcomes, such infection site, phage–host specificity, burden, immune response. Additionally, innovative strategies—such combination therapies, bioengineered phages, cocktails—were explored enhance efficacy. Critical considerations related dosing, including inoculum size, multiplicity infection, windows, personalized medicine approaches, were examined optimize outcomes. Results: has demonstrated favorable safety profile in both settings, with minimal adverse effects. Its ability specifically target harmful bacteria while preserving beneficial microbiota underpins efficacy treating range infections. However, variable outcomes some studies highlight importance addressing critical that influence success. Innovative expanded access diverse banks, cocktails, medicine, hold significant promise improving Optimizing dosing remains area enhancement, kinetics, resistance potential, frequency, patient-specific factors. To support streamlined four-step guideline been developed, providing effective planning Conclusion: offers highly adaptable, targeted, cost-effective approach While several must be thoroughly evaluated there improvement through refined methodologies. Although yet achieve widespread approval U.S. Europe, accessibility Expanded Access programs FDA authorizations food pathogen control underscores promise. Established practices countries Poland Georgia further demonstrate feasibility. enable broader adoption, harmonization advancements production, delivery, quality will essential. Notably, affordability scalability position it especially valuable solution developing regions grappling escalating rates antibiotic resistance.

Language: Английский

Citations

7

Total Synthesis of a Conjugation-Ready Tetrasaccharide Repeating Unit of Vibrio cholerae O:3 O-antigen Polysaccharide DOI

Soumyakanta Maji,

Balasaheb K. Ghotekar,

Suvarn S. Kulkarni

et al.

Organic Letters, Journal Year: 2024, Volume and Issue: 26(3), P. 745 - 750

Published: Jan. 10, 2024

Herein, we report the first total synthesis of tetrasaccharide repeating unit Vibrio cholerae O:3 O-antigen polysaccharide. The highly complex contains rare amino sugars such as d-bacillosamine and l-fucosamine, labile sugar ascarylose, higher carbon d-d-heptose. Stereoselective glycosylation notoriously reactive ascarylose with d-d-heptose, poor nucleophilicity axial C4-OH amide coupling are key challenges encountered in synthesis, which was completed via a longest linear sequence 23 steps 4.2% overall yield.

Language: Английский

Citations

6

Evaluation of humoral and cellular immune responses against Vibrio cholerae using oral immunization by multi-epitope-phage-based vaccine DOI
Elham Ghafouri, Mahmood Fadaie,

Zohre Amirkhani

et al.

International Immunopharmacology, Journal Year: 2024, Volume and Issue: 134, P. 112160 - 112160

Published: May 5, 2024

Language: Английский

Citations

6

Understanding Mucosal Physiology and Rationale of Formulation Design for Improved Mucosal Immunity DOI

Mila Biswas,

Md Nurunnabi, Zehedina Khatun

et al.

ACS Applied Bio Materials, Journal Year: 2024, Volume and Issue: 7(8), P. 5037 - 5056

Published: May 24, 2024

The oral and nasal cavities serve as critical gateways for infectious pathogens, with microorganisms primarily gaining entry through these routes. Our first line of defense against invaders is the mucosal membrane, a protective barrier that shields body's internal systems from infection while also contributing to vital functions like air nutrient intake. One key features this its ability protect physiological system pathogens. Additionally, tolerance plays crucial role in maintaining homeostasis by regulating pH water balance within body. Recognizing importance barrier, researchers have developed various formulations enhance immune response. Mucosal vaccines, example, deliver antigens directly tissues, triggering local stimulation ultimately inducing systemic immunity. Studies shown lipid-based such liposomes virosomes can effectively elicit both responses. Furthermore, mucoadhesive polymeric particles, their prolonged delivery target sites, demonstrated an enhanced This Review delves into material selection approaches optimizing

Language: Английский

Citations

6

Hemolysin Coregulated Protein (HCP) from Vibrio Cholerae Interacts with the Host Cell Actin Cytoskeleton DOI
Shubham Das, Saikat Chandra Das, Pragyan Parimita Rath

et al.

ACS Infectious Diseases, Journal Year: 2024, Volume and Issue: 10(8), P. 2886 - 2898

Published: July 30, 2024

Vibrio cholerae (V. cholerae), the etiological agent of cholera, employs various virulence factors to adapt and thrive within both aquatic human host environments. Among these factors, type VI secretion system (T6SS) stands out as one crucial determinants its pathogenicity. Valine glycine repeat protein G1 (VgrG1) hemolysin coregulated (HCP) are considered major effector molecules T6SS. Previous studies have highlighted that VgrG1 interacts with HCP proteins. Additionally, it has been shown possesses an actin cross-linking domain (ACD) actin-binding activity. Interestingly, was reported purified treatment increased stress fibers cells. Therefore, we hypothesize may interact cell actin, potentially playing a role in cytoskeletal rearrangement during V. infection. To test this hypothesis, characterized from O139 serotype demonstrated interaction monomers. In silico analysis experimental validation revealed presence site HCP. Furthermore, overexpression resulted colocalization Our findings establish molecule for potent cytoskeleton remodeling infection, providing new insights into bacterial pathogenicity mechanisms. Understanding interplay between effectors components is developing targeted therapeutic interventions against cholera related infectious diseases.

Language: Английский

Citations

6

Non-O1/Non-O139 Vibrio cholerae—An Underestimated Foodborne Pathogen? An Overview of Its Virulence Genes and Regulatory Systems Involved in Pathogenesis DOI Creative Commons

Quantao Zhang,

Thomas Alter,

Susanne Fleischmann

et al.

Microorganisms, Journal Year: 2024, Volume and Issue: 12(4), P. 818 - 818

Published: April 18, 2024

In recent years, the number of foodborne infections with non-O1 and non-O139

Language: Английский

Citations

5

Porphyromonas gingivalis Vaccine: Antigens and Mucosal Adjuvants DOI Creative Commons
Shuo Wang, Yan Tong,

Bingtao Zhang

et al.

Vaccines, Journal Year: 2024, Volume and Issue: 12(6), P. 619 - 619

Published: June 4, 2024

Porphyromonas gingivalis (Pg), a Gram-negative anaerobic bacterium found in dental plaque biofilm within periodontal pockets, is the primary pathogenic microorganism responsible for chronic periodontitis. Infection by Pg significantly impacts development and progression of various diseases, underscoring importance eliminating this effective clinical treatment. While antibiotics are commonly used to combat Pg, rise antibiotic resistance poses challenge complete eradication. Thus, prevention infection paramount. Research suggests that surface antigens such as fimbriae, outer membrane proteins, gingipains, can potentially be utilized vaccine trigger protective immune responses. This article overviews these antigens, discusses advancements mucosal adjuvants (including immunostimulant vaccine-delivery adjuvants), their application development. Furthermore, review examines advantages disadvantages different pathways common routes immunization. By summarizing current landscape vaccines, addressing existing challenges, highlighting potential offers new insights advancement implementation vaccines.

Language: Английский

Citations

4

Mitogen-Activated Protein Kinases (MAPKs) and Enteric Bacterial Pathogens: A Complex Interplay DOI Open Access
Ipsita Nandi, Benjamin Aroeti

International Journal of Molecular Sciences, Journal Year: 2023, Volume and Issue: 24(15), P. 11905 - 11905

Published: July 25, 2023

Diverse extracellular and intracellular cues activate mammalian mitogen-activated protein kinases (MAPKs). Canonically, the activation starts at cell surface receptors continues via MAPK components, acting in host nucleus as activators of transcriptional programs to regulate various cellular activities, including proinflammatory responses against bacterial pathogens. For instance, binding pattern recognition (PRRs) on intestinal epithelial cells pathogen external components trigger MAPK/NF-κB signaling cascade, eliciting cytokine production. This results an innate immune response that can eliminate pathogen. However, enteric pathogens evolved sophisticated mechanisms interfere with such a by delivering virulent proteins, termed effectors, toxins into cells. These proteins act numerous ways inactivate or critical cascades immunity. The consequence activities could lead successful colonization, dissemination, pathogenicity. article will review pathogens’ strategies modulate MAPKs responses. It also discuss findings attempting develop anti-microbial treatments targeting MAPKs.

Language: Английский

Citations

10

Cholera Outbreaks in Low- and Middle-Income Countries in the Last Decade: A Systematic Review and Meta-Analysis DOI Creative Commons
Anastasia A. Asantewaa, Alex Odoom, Godfred Owusu-Okyere

et al.

Microorganisms, Journal Year: 2024, Volume and Issue: 12(12), P. 2504 - 2504

Published: Dec. 4, 2024

Cholera is linked to penury, making low- and middle-income countries (LMICs) particularly vulnerable outbreaks. In this systematic review, we analyzed the drivers contributing these outbreaks, focusing on epidemiology of cholera in LMICs. This review followed Preferred Reporting Items for Systematic Reviews Meta-Analyses (PRISMA) guidelines was registered PROSPERO (ID: CRD42024591613). We searched PubMed, Scopus, Web Science, Google Scholar include studies outbreaks that occurred LMICs from 1 January 2014 21 September 2024. Studies outside sporadic cases were excluded. The risk bias among included assessed using a modified Downes et al. appraisal tool. Thematic analysis used synthesize qualitative data, meta-analyses estimate pooled prevalence. From 1662 records, 95 met inclusion criteria, primarily documenting Africa (74%) Asia (26%). Contaminated water main route disease transmission. fatality prevalence 1.3% (95% CI: 1.1–1.6), detection rate suspected 57.8% 49.2–66.4). Vibrio cholerae O1 dominant serogroup while Ogawa serotype. All reporting biotypes indicated El Tor. Although isolates 100% susceptible ofloxacin, levofloxacin, norfloxacin, cefuroxime, doxycycline, they also fully resistant amikacin, sulfamethoxazole, trimethoprim, furazolidone. persistence destitute areas with limited access clean sanitation emphasizes need socioeconomic improvements, infrastructure development, ongoing surveillance support timely responses achieve long-term prevention.

Language: Английский

Citations

4